Poolbeg Pharma (OTCQB: POLBF) is a clinical stage infectious disease pharmaceutical company with a capital light clinical model which is looking to develop multiple products faster and more cost effectively than the conventional biotech model. CEO Jeremy Skillington joins us to discuss how the Covid-19 pandemic has impacted the company’s research on infectious diseases.